Drugs giant AstraZeneca has revealed plans to overhaul its US listing, but stressed it will keep its headquarters in the UK and remain on the London market. Cambridge-based AstraZeneca is set to ...

Astrazeneca has laid out plans aimed at “upgrading” its US listing in the latest blow to the London Stock Exchange. The Cambridge-based pharma giant said it would replace its existing Nasdaq listing ...

(Reuters) -AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit. Suarez will lead the execution of the ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has proudly awarded $3.4 million to nonprofit organizations in the US through its Accelerate Change Together (ACT) on Health Equity initiative. This ...

US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date AstraZeneca has proudly awarded $3.4 million to nonprofit ...